ArticleNaunyn-Schmiedeberg's archives of pharmacology2021

Chronic treatment with the (iso-)glutaminyl cyclase inhibitor PQ529 is a novel and effective approach for glomerulonephritis in chronic kidney disease.

Naotoshi Kanemitsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.